These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 7199779

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN, Andreenko GV, Tsymanovich SG, Maksimova RA, Sharkova TS.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [Abstract] [Full Text] [Related]

  • 3. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
    Andreenko GV, Shimonaeva EE, Liutova LV, Serebriakova TN.
    Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro.
    Korninger C, Collen D.
    Thromb Haemost; 1981 Aug 28; 46(2):561-5. PubMed ID: 6795744
    [Abstract] [Full Text] [Related]

  • 7. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV, Serebriakova TN, Shimonaeva EE, Liutova LV, Karabasova MA.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983 Aug 28; (3):51-4. PubMed ID: 6342687
    [Abstract] [Full Text] [Related]

  • 8. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
    Schultze AE, Roth RA.
    Toxicol Appl Pharmacol; 1993 Jul 28; 121(1):129-37. PubMed ID: 7687795
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 28; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Peripheral and gastric fibrinolysis in patients with gastric carcinoma.
    Prokopowicz J, Gabryelewicz A, Wołosowicz N, Szałaj W, Puchalski Z.
    Z Exp Chir; 1975 Jul 28; 8(5):309-12. PubMed ID: 1053190
    [Abstract] [Full Text] [Related]

  • 13. [State of the fibrinolytic and kinin systems of the blood after physical loading].
    Andreenko GV, Liutova LV, Beniumova OE.
    Fiziol Zh SSSR Im I M Sechenova; 1980 Oct 28; 66(10):1473-80. PubMed ID: 7192224
    [Abstract] [Full Text] [Related]

  • 14. Proteolysis of fibrinogen in healthy volunteers following major and minor vivo plasminogen activation.
    Prowse CV, Dawes J, Lane DA, Ireland H, Knight I.
    Thromb Res; 1982 Jul 01; 27(1):91-7. PubMed ID: 6750837
    [Abstract] [Full Text] [Related]

  • 15. [Various fibrinolytic and coagulation characteristics of the blood plasma after contact with N-amyl alcohol].
    Lussa A, Tymińska-Brzósko R.
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1979 Jul 01; 24():91-104. PubMed ID: 161647
    [No Abstract] [Full Text] [Related]

  • 16. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
    Aznar J, Estellés A, Vila V, Regañón E, España F, Villa P.
    Thromb Haemost; 1984 Oct 31; 52(2):196-200. PubMed ID: 6543037
    [Abstract] [Full Text] [Related]

  • 17. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
    Theiss W, Asbeck F, Kriessmann A, Trübestein G, Knoch K, de Swart CA, Marbert GA, van de Loo JC.
    Thromb Haemost; 1983 Oct 31; 50(3):664-8. PubMed ID: 6196852
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.